Top news
Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla
Gottlieb says Biden administration "in a better position" for booster rollout but worries vaccine mandate will harden skeptics
By Shani Benezra
FDA advisory group rejects Covid boosters for most, limits to high-risk groups
All coverage
Moderna says COVID-19 vaccine protection wanes, makes case for booster
By Julie Steenhuysen
New Study of Covid Booster Shots Fans Debate Over Benefits (Published 2021)
By Apoorva Mandavilli
FDA advisory panel rejects widespread Pfizer vaccine booster shots
By Lauran Neergaard & Matthew Perrone
Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC-led study says
By Maggie Fox
FDA panel recommends Pfizer's Covid booster doses for people 65 and older after rejecting third shots for general population
By Berkeley Lovelace, Robert Towey & Berkeley Lovelace Jr.